The chemical class referred to as PLSCR3 inhibitors pertains to a diverse set of organic compounds characterized by their capacity to selectively interfere with the activity of Phospholipid Scramblase 3 (PLSCR3), a pivotal protein implicated in the intricate orchestration of cellular events involving the translocation of phospholipids across cell membranes. Of paramount importance in processes such as apoptosis, PLSCR3's function revolves around the redistribution of membrane phospholipids, thus exerting a notable influence on various physiological phenomena within the cell.
The distinct characteristic of PLSCR3 inhibitors is their ability to specifically target and modulate the actions of this protein, which can culminate in consequential changes in the lipid makeup of cellular membranes. This class of inhibitors is meticulously developed through methods including rational drug design or high-throughput screening, aiming to pinpoint precise binding sites or interactive regions on PLSCR3's intricate three-dimensional structure. The endeavors within this chemical class are emblematic of the intricate pursuit to unravel the nuances of PLSCR3's role in membrane dynamics and its intricate involvement in cellular signaling pathways, providing a foundation for nuanced insights into its functional implications.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Calpeptin | 117591-20-5 | sc-202516 sc-202516A | 10 mg 50 mg | $121.00 $456.00 | 28 | |
Calpeptin is a cell-permeable inhibitor that has been reported to inhibit the translocation of phosphatidylserine by PLSCR3 during apoptosis. It functions by inhibiting calpain, a calcium-dependent protease that is involved in various cellular processes, including apoptosis. | ||||||